Envista/NVST

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Envista

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

Ticker

NVST

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Paul Keel

Employees

12,800

Headquarters

Brea, United States

Envista Metrics

BasicAdvanced
$3.3B
Market cap
-
P/E ratio
-$0.71
EPS
1.34
Beta
-
Dividend rate
$3.3B
1.33868
$36.14
$17.64
2.1M
2.268
1.926
33.585
36.374
5.09%
-1.83%
-2.86%
-2.15%
1.298
0.804
12.738
-0.08%
-159.61%
9.98%

What the Analysts think about Envista

Analyst Ratings

Majority rating from 13 analysts.
Hold

Envista Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
3.78% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$624M
-3.41%
Net income
$24M
-110.86%
Profit margin
3.78%
-111.23%

Envista Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 17.46%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.43
$0.43
$0.29
$0.26
-
Expected
$0.41
$0.46
$0.34
$0.32
$0.30
Surprise
4.78%
-6.11%
-14.82%
-17.46%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Envista stock?

Envista (NVST) has a market cap of $3.3B as of June 17, 2024.

What is the P/E ratio for Envista stock?

The price to earnings (P/E) ratio for Envista (NVST) stock is 0 as of June 17, 2024.

Does Envista stock pay dividends?

No, Envista (NVST) stock does not pay dividends to its shareholders as of June 17, 2024.

When is the next Envista dividend payment date?

Envista (NVST) stock does not pay dividends to its shareholders.

What is the beta indicator for Envista?

Envista (NVST) has a beta rating of 1.34. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Envista stock price target?

The target price for Envista (NVST) stock is $20.25, which is NaN% below the current price of $. This is an average based on projections from 10 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Envista stock

Buy or sell Envista stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing